Endocrinology Drugs Market by Therapy Area and Geography - Forecast and Analysis 2021-2025

  • Published: May 2021
  • Pages: 120
  • SKU: IRTNTR40785

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The endocrinology drugs market has the potential to grow by USD 25.25 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 6.26%.

This endocrinology drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by therapy area (diabetes drugs, hGH, thyroid hormone disorders, and others) and geography (North America, Europe, Asia, and ROW). The endocrinology drugs market report also offers information on several market vendors, including Acerus Pharmaceuticals Corp., Beta Cell NV, Eli Lilly and Co., GlaxoSmithKline Plc, Ipsen Pharma SA, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., and Sanofi SA among others.

What will the Endocrinology Drugs Market Size be in 2021?


Browse TOC and LoE with selected illustrations and example pages of Endocrinology Drugs Market

 Get Your FREE Sample Now!

Endocrinology Drugs Market: Key Drivers and Trends

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increase in incidence of endocrine disorders is notably driving the endocrinology drugs market growth, although factors such as patent expiry of major endocrinology drugs may impede market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the endocrinology drugs industry get your FREE report sample now.

  • The growing prevalence of endocrine disorders is one of the critical reasons driving the endocrinology drugs market growth.
  • The number of patients with endocrine disorders is increasing with the rising aging population across the world.
  • A common trend noticed in the incidence of endocrinology disorders like diabetes is the prevalence in countries with low and middle-income.
  • Diabetes poses a serious threat to wellbeing as it can lead to other diseases. As a result, the demand for endocrinology drugs is increasing rapidly.
  • The association between obesity and endocrine disorders will fuel the need for endocrinology drugs.
  • Incidences of endocrine disorders such as PCOS, hypothyroidism, and diabetes may occur due to obesity, which is a common ailment arising from modern sedentary lifestyles.
  • Obesity may result in endogenous hormonal systems alterations in some patients.

This endocrinology drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.

Who are the Major Endocrinology Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:


  • Acerus Pharmaceuticals Corp.
  • Beta Cell NV
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Ipsen Pharma SA
  • Merck and Co. Inc.
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.
  • Sanofi SA


The endocrinology drugs market is fragmented and the vendors are deploying growth strategies such as acquisitions, entering distribution agreements, expanding into untapped markets, and launching several new products to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the endocrinology drugs market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Endocrinology Drugs Market?


For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for endocrinology drugs in North America. However, the market growth rate in this region will be slower than the growth of the market in Asia and Europe.

The growing aging population, which increases the risk of endocrine disorders, will facilitate the endocrinology drug market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Therapy Area Segments in the Endocrinology Drugs Market?

Endocrinology-Drugs-Market-Market-Share-by-Therapy Area-2020-2025

To gain further insights on the market contribution of various segments Request for a FREE sample

The endocrinology drugs market share growth by the diabetes drugs segment will be significant during the forecast period. The diabetes drugs segment will contribute to the growth of the market in focus due to the increasing incidence of diabetes. The recent trends of using diabetic drugs off-label for weight loss also contribute to endocrinology drugs market growth.

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the endocrinology drugs market size.



Request for a FREE sample

What are the Key Factors Covered in this Endocrinology Drugs Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive endocrinology drugs market growth during the next five years
  • Precise estimation of the endocrinology drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the endocrinology drugs industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of endocrinology drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The endocrinology drugs market growth will increase by $24.78 billion during 2019-2024.
The endocrinology drugs market is expected to grow at a CAGR of 6.63% during 2019-2024.
Technavio has segmented the endocrinology drugs market by other1 (Diabetes drugs, hGH, Thyroid hormone disorders, Testosterone replacement therapy, and Others) and geographic (North America, Europe, Asia, and ROW).
Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Eli Lilly and Co., GlaxoSmithKline Plc, Groupe Sanofi, Merck & Co. Inc., Novartis International AG, Novo Nordisk AS, Pfizer Inc. are a few of the key vendors in the endocrinology drugs market.
North America will register the highest growth rate of 44.77% among the other regions. Therefore, the endocrinology drugs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
  • US
  • UK
  • France
  • Canada
  • Germany
  • Japan
The key factors driving the endocrinology drugs market growth are:
  • Increase in incidence of endocrine disorders
  • Association between obesity and endocrine disorders
The endocrinology drugs market vendors should focus on grabbing business opportunities from the diabetes drugs segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.


Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>